SPONSOR
Jina Pharmaceuticals Inc.
Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Triple Negative Breast Cancer
Jina Pharmaceuticals Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Triple Negative Breast Cancer.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Jina Pharmaceuticals Inc.
How many clinical trials has Jina Pharmaceuticals Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Jina Pharmaceuticals Inc., of which 1 are actively recruiting participants. These trials cover conditions including Triple Negative Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Jina Pharmaceuticals Inc. research focus on?
Jina Pharmaceuticals Inc. clinical trials span Triple Negative Breast Cancer. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Jina Pharmaceuticals Inc. clinical trial?
To participate in a Jina Pharmaceuticals Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Jina Pharmaceuticals Inc. trials with current recruitment status updated daily.
Clinical Trials by Jina Pharmaceuticals Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology